Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD (SPin-D): A Randomized, Placebo-Controlled, Multiple Dosage Trial.

Authors

David M Charytan
Jonathan Himmelfarb
T Alp Ikizler
Dominic S Raj, George Washington University
Jesse Y Hsu
J Richard Landis
Amanda H Anderson
Adriana M Hung
Rajnish Mehrotra
Shailendra Sharma
Daniel E Weiner
Mark Williams
Marcelo DiCarli
Hicham Skali
Paul L Kimmel
Alan S Kliger
Laura M Dember

Document Type

Journal Article

Publication Date

11-22-2018

Journal

Kidney International

DOI

10.1016/j.kint.2018.08.034

Comments

Epub ahead of print

APA Citation

Charytan, D., Himmelfarb, J., Ikizler, T., Raj, D., Hsu, J., Landis, J., Anderson, A., Hung, A., Mehrotra, R., Sharma, S., Weiner, D., Williams, M., DiCarli, M., Skali, H., Kimmel, P., Kliger, A., & Dember, L. (2018). Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD (SPin-D): A Randomized, Placebo-Controlled, Multiple Dosage Trial.. Kidney International, (). http://dx.doi.org/10.1016/j.kint.2018.08.034

Peer Reviewed

1